期刊文献+

P21基因参与早期诱导RUNX1b过表达抑制人类造血发生

P21 gene is involved in early inducible overexpression of RUNX1b and blocks the human hematopoiesis
下载PDF
导出
摘要 目的探究细胞周期蛋白依赖性激酶抑制剂1[CDKN1A(P21)]对造血发生过程的影响。方法对RUNX1b诱导过表达hES细胞系(RUNX1b/hESC)与小鼠主动脉-性腺-中肾区(AGM)基质细胞AGM-S3共培养4 d细胞,使用多西环素(DOX)(1μg/mL)与RepSox(0.33μmol/L)或不同浓度DOX(1、0.5、0.2、0.1μg/mL)诱导RUNX1b过表达时,以qRT-PCR技术检测P21与RUNX1b相对表达情况。利用基于转座子载体PiggyBac的PB-tet-on-OE真核诱导过表达系统,建立P21诱导过表达hES细胞系(CDKN1A/hESC)。分别在CDKN1A/hESC与AGM-S3共培养d0、d2、d4、d6添加DOX诱导P21过表达,培养8 d或14 d,通过流式细胞术(FACS)检测血细胞表面分子的变化情况,以判断诱导P21过表达对造血发生产生的影响。结果 qRT-PCR显示:P21表达量随着RUNX1b过表达上调,同时加入RepSox时表达基本处在正常水平,随着DOX浓度降低,RUNX1b与P21表达水平下降。在造血分化的早期,特别是共培养d0开始诱导P21过表达的共培养体系所产生的CD34^-CD43^+、CD34^-CD45^+与CD34^+CD45^+细胞群相较于对照分别降低了85%,94%和78%,当共培养d6后诱导P21过表达上述现象消失。结论 P21可能参与了由RUNX1b诱导过表达所引起的人类早期造血发生的抑制效应;早期诱导P21过表达明显抑制造血细胞产生。 Objective To investigate the effect of cyclin-dependent kinase inhibitor 1[CDKN1A(P21)]on hematopoiesis.Methods The co-cultured d4 cells of inducible RUNX1b hESC line(RUNX1b/hESC)with mouse aorta/gonad/mesonephros(AGM-S3),using doxycycline(DOX)(1μg/mL)and RepSox(0.33μmol/L)or different concentrations of DOX(1,0.5,0.2,and 0.1μg/mL)to induce RUNX1b overexpression,qRT-PCR was used to detect the relative expression of P21 and RUNX1b.Eukaryotic inducible system based on piggyBac,PB-tet-on-OE,was used to establish inducible P21 hESC line(CDKN1A/hESC).DOX was added in CDKN1A/hESC and co-cultured with AGM-S3 from 0,2,4 d,and d6 respectively,to induce P21 overexpression.At co-cultured d8 and d14,fluorescence-activated cell sorting(FACS)was used to detect changes of surface molecules of hematopoietic cells,and investigate the effect of P21 overexpression on hematopoiesis.Results qRT-PCR showed that the expression of P21 was up-regulated together with RUNX1b overexpression,and the expression of P21 was restored to the normal level when RepSox was added.As the concentration of DOX decreased,the expression of RUNX1b and P21 also decreased.Overexpression of P21 from early stage of hematopoiesis,especially CD34^-CD43^+,CD34^-CD45^+,CD34^+CD45^+populations from 0 d,decreased by 85%,94%,and 78%,respectively,when compared with the control group,but the above overexpression disappeared when induced after 6 days.Conclusion P21 is probably involved in inhibitory effect of human hematopoiesis caused by overexpression of RUNX1b at early stage;induction of P21 overexpression from early stage significantly blocks the product of hematopoietic cells.
作者 常晶 滕嘉雯 孙文翠 曾加辉 张勇刚 潘旭 周涯 赖默温 边国慧 周琼秀 刘嘉馨 陈波 马峰 CHANGJing;TENG Jiawen;SUN Wencui;ZENG Jiahui;ZHANG Yonggang;PAN Xu;ZHOU Ya;LAI Mowen;BIAN Guohui;ZHOU Qiongxiu;LIU Jiaxing;CHEN Bo;MA Feng(Institute of Blood Transfusion,Chinese Academy of Medical Sciences&Peking Union Medical College(CAMS&PUMC),Chengdu 610052,China;State Key Laboratory of Experimental Hematology,CAMS&PUMCState Key Laboratory of Biotherapy,Sichuan University)
出处 《中国输血杂志》 CAS 2019年第3期222-227,共6页 Chinese Journal of Blood Transfusion
基金 中国医学科学院医学与健康科技创新工程(2016-I2M-1-018 2017-I2M-3-021) 四川省卫生计划生育委员会研究项目(17PJ489)
关键词 细胞周期蛋白依赖性激酶抑制剂[CDKN1A(P21)] 多西环素(DOX) 真核诱导过表达系统 人胚胎干细胞(hESC) 主动脉-性腺-中肾(AGM)基质细胞 造血发生 cyclin-dependent kinase inhibitor 1[CDKN1A(P21)] doxycycline(DOX) eukaryotic inducible system hESC aorta/gonad/mesonephros(AGM) hematopoiesis
  • 相关文献

参考文献5

二级参考文献16

  • 1Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclindepedent kinase inhibitor p27 couple with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells.Pro
  • 2Cheng T , Rodrigues N, Dombkowski D, et al. Stem cell repopulation efficiency but not pool size is governed by p27. Nat Med,2000,6:1235-1240.
  • 3Cheng T, Shen HM, Rodrigues N, et al. Transforming growth fator beta-1 mediates cell cycle arrest of primitive hematopoietic cells independent of p21 or p27. Blood, 2001,98:3643-3649.
  • 4Dao MA, Hwa J, Nolta JA, et al. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34+ progenitor. Blood, 2002,99:499-506.
  • 5Bradford GB, Williams B, Rossi R, et al. Quiescence cycling,and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol, 1997,25:445-453.
  • 6Halstead BW, Tong X, Traycoff CM, et al. Proliferation kinectics and length of cell cycle of individual long-term initiative cells (LTC-IC). Exp Hematol, 1998,26:684.
  • 7Ruscetti FW,Jacobsen SE, Birchenal-Roberts M, et al. Role of transforming growth favtor-beta 1 in regulation of hematopoiesis.Ann N Y Acad Sci, 1991, 628:31-43.
  • 8Cheng T,Scadden DT. Cell cycle entry of hematopoietic stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors . Inter J Hematol, 2002,75:460.
  • 9Cheng T, Nei R, Shen H, et al. Hematopoietic stem cell quiescence maitaind by p21. Science, 2000,287:1804-1808.
  • 10Stier S, Cheng T, Forkert R, et al. Ex vivo targeting of p21 permits relative expansion of human hematopoietic stem cells.Blood, 2003,102:1260-1266.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部